Preventing Peanut Allergy: First Food Item with FDA-Backed Health Claim Hits Market — Physician’s First Watch

Medical News |
September 18, 2017

Preventing Peanut Allergy: First Food Item with FDA-Backed Health Claim Hits Market

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

A food product with a label claiming it may help prevent peanut allergies has hit the market, the New York Times reports. Hello, Peanut — a powder made of organic peanuts and oat blends — is the first food item to carry the FDA-backed health claim.

The powder is meant to be mixed with pureed baby food soon after an infant begins eating solid foods. There's an introductory kit, which slowly increases the amount of peanut every day for a week. This is followed by maintenance packets — which include 2 grams of peanut powder daily (equal to 3-7 peanuts) — that the child eats until he or she can consume peanut butter.

High-risk infants, including those with severe eczema or egg allergy, should undergo allergy testing before using Hello, Peanut.

The introductory kit costs $25, and each maintenance kit costs $20. Experts say mixing smooth creamy peanut butter with warm water is a less costly alternative, the Times notes.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.